Harold William Burke, MD

Dr. Lee Hunter Riley III is a professor of orthopaedic surgery and neurological surgery at the Johns Hopkins University School of Medicine. He serves as vice director of clinical operations in the Department of Orthopaedic Surgery. He specializes in surgical treatments for spinal disorders and injuries.Dr. Riley received his M.D. from the Johns Hopkins University School of Medicine in 1986. Following a residency in orthopaedic surgery and a fellowship in spinal surgery at Johns Hopkins, he completed a second fellowship in spinal surgery at the University of Miami School of Medicine in 1993.In addition to clinical interests in the cervical spine and adult spinal disorders, his research interests include disc degeneration, metastatic disease, vertebroplasty and cervical spine disorder.Dr. Riley has authored or co-authored over 100 scholarly publications.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer.